Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
24,200
+400 (1.68%)
At close: Feb 13, 2026
Market Cap168.65B +50.5%
Revenue (ttm)66.51B -10.3%
Net Income2.32B
EPS340.76
Shares Out6.97M
PE Ratio71.02
Forward PEn/a
Dividend1,000.00 (4.13%)
Ex-Dividend DateDec 29, 2025
Volume45,403
Average Volume20,067
Open24,900
Previous Close23,800
Day's Range23,900 - 25,150
52-Week Range14,500 - 31,450
Beta-0.34
RSI64.44
Earnings DateFeb 26, 2026

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements